To study effect of Vranropana Taila Guggulyadi Dhupana and both on Episiotomy
Phase 1
- Conditions
- Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
- Registration Number
- CTRI/2019/04/018655
- Lead Sponsor
- Gitanjali Vaiti
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
full term patient delivered with Episiotomy
Exclusion Criteria
patient with bleeding disorders
severe anaemia
DM
GDM
local skin disease of perineum
HIV vdrl hbsag positive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy of single and combined effect of Vranropana Taila application and Guggulyadi Dhupana on EpisiotomyTimepoint: 8 days
- Secondary Outcome Measures
Name Time Method to study Episiotomy <br/ ><br>to observe any adverse effect of Vranropana Taila application Guggulyadi Dhupana and combined effect on EpisiotomyTimepoint: 8 days